Therapeutic Effect of Apheresis and Buffy Coat-Derived Platelet Concentrates

被引：0
|
作者：
Zimmermann, Robert [1 ]
机构：
[1] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Dept Transfus Med & Hemostaseol, Erlangen, Germany
来源：
CLINICAL LABORATORY | 2024年 / 70卷 / 08期
关键词：
platelets; platelet function; platelet concentrates; plateletpheresis;
D O I：
10.7754/Clin.Lab.2024.240728
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1431 / 1433
页数：3
相关论文
共 50 条
  • [41] Superior integrin activating capacity and higher adhesion to fibrinogen matrix in buffy coat-derived platelet concentrates (PCs) compared to PRP-PCs
    Beshkar, Pezhman
    Hosseini, Ehteramolsadat
    Ghasemzadeh, Mehran
    TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (01) : 76 - 81
  • [42] Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution
    Johnson, L. N.
    Winter, K. M.
    Reid, S.
    Hartkopf-Theis, T.
    Marks, D. C.
    CRYOBIOLOGY, 2011, 62 (02) : 100 - 106
  • [43] Rhesus D Antigenic Determinants on Residual Red Blood Cells in Apheresis and Buffy Coat Platelet Concentrates
    Thibault, Louis
    de Grandmont, Marie Joelle
    Cayer, Marie-Pierre
    Dussault, Nathalie
    Jacques, Annie
    Ducas, Eric
    Beausejour, Annie
    Lebrun, Andre
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2020, 47 (02) : 129 - 134
  • [44] Platelet transfusion reactions do not occur more often in recipients transfused with apheresis versus buffy coat platelet concentrates
    Cserti-Gazdewich, Christine
    Escorcia, Alioska
    Pendergrast, Jacob
    Lieberman, Lani
    Skeate, Robert
    Lin, Yulia
    Callum, Jeannie
    TRANSFUSION, 2016, 56 (12) : 3144 - 3147
  • [45] The history of buffy coat platelet concentrates: The Dutch story
    van der Meer, Pieter F.
    Reesink, Hendrik W.
    de Korte, Dirk
    Loos, Johannes A.
    Klei, Thomas R. L.
    VOX SANGUINIS, 2022, 117 (07) : 913 - 919
  • [46] Are Buffy-coat Pooled Platelet Concentrates an Effective Alternative to Apheresis Platelet Concentrates? An In vitro Analysis at a Tertiary Care Center in Northern India
    Agarwal, Prashant
    Jain, Ashish
    Elhence, Priti
    Verma, Anupam
    INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH, 2023, 13 (03) : 175 - 179
  • [47] A system for the supply of platelets suspended in a storage medium including buffy-coat-derived platelet concentrates in combination with ''split'' apheresis platelets
    Gulliksson, H
    Larsson, S
    Shanwell, A
    Pedajas, I
    Joie, M
    Flament, J
    TRANSFUSION SCIENCE, 1997, 18 (01): : 33 - 40
  • [48] Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy
    Akkok, C. A.
    Brinch, L.
    Lauritzsen, G. F.
    Solheim, B. G.
    Kjeldsen-Kragh, J.
    VOX SANGUINIS, 2007, 93 (01) : 42 - 48
  • [49] Pilot study of routine use of intercept treated buffy coat derived platelet concentrates
    Lozano, M
    Arenilla, L
    Perea, D
    Jané, M
    Lachén, M
    Mazzara, R
    TRANSFUSION, 2005, 45 (03) : 109A - 109A
  • [50] INVITRO EVALUATION OF BUFFY-COAT-DERIVED PLATELET CONCENTRATES STORED IN A SYNTHETIC MEDIUM
    FIJNHEER, R
    VELDMAN, HA
    VANDENEERTWEGH, AJM
    GOUWEROK, CWN
    HOMBURG, CHE
    BOOMGAARD, MN
    DEKORTE, D
    ROOS, D
    VOX SANGUINIS, 1991, 60 (01) : 16 - 22
12345